Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,941,088
-$193,918 QoQ
Shares Held
80,610
+6.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#980
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keystone Financial Group holds $28,513,517 across 12 Drug Manufacturers - General names. PFE ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,287 | $12,009,479 | |
| 2 | LLY |
ELI LILLY & Co
|
4,531 | $5,434,617 | |
| 3 | ABBV |
AbbVie Inc.
|
14,346 | $3,610,027 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,960 | $2,564,860 | |
| 5 | PFE |
Pfizer Inc
This page
|
80,610 | $1,941,088 | |
| 6 | AMGN |
Amgen Inc
|
2,034 | $736,552 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,142 | $523,300 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,578 | $494,264 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,941,088 | 80,610 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,135,006 | 76,033 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,690,934 | 67,909 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,145,849 | 84,217 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,307,793 | 95,206 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,273,555 | 89,722 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,848,689 | 69,683 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,029,967 | 70,144 | Shares | Sole | 2025-02-19 | |
| 2024-06-30 | $1,694,804 | 60,572 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,446,441 | 52,124 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,091,400 | 37,909 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,140,052 | 34,370 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,182,306 | 32,233 | Shares | Sole | 2023-08-07 | |
| 2022-12-31 | $1,444,096 | 28,183 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,238,145 | 28,294 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,428,927 | 27,254 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,411,819 | 27,271 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,511,561 | 25,598 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $929,962 | 21,622 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $831,445 | 21,232 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $761,916 | 21,030 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $725,157 | 19,700 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $683,353 | 18,620 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $574,539 | 17,570 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $570,187 | 17,469 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||